Development and evaluation of the MiCheck ® Prostate test for clinically significant prostate cancer

CONCLUSIONS: The MiCheck® Prostate test identifies clinically significant prostate cancer with high sensitivity and negative predictive value (NPV). It can be performed in a clinical laboratory using a Roche Cobas clinical chemistry analyzer. The MiCheck® Prostate test could assist in reducing unnecessary prostate biopsies with a marginal number of patients experiencing a delayed diagnosis.PMID:37734979 | DOI:10.1016/j.urolonc.2023.08.005

Source: Urologic Oncology - September 21, 2023 Category: Urology & Nephrology Authors: Neal D Shore Dmitry M Polikarpov Christopher M Pieczonka R Jonathan Henderson James L Bailen Daniel R Saltzstein Raoul S Concepcion Jennifer L Beebe-Dimmer Julie J Ruterbusch Rachel A Levin Sandra Wissmueller Thao Ho Le David A Gillatt Daniel W Chan Niant Source Type: research